Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U1111-1147-4202 | Other Identifier | WHO |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This survey is conducted in South America. The purpose is to identify the key psychosocial issues affecting patients with haemophilia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| survey |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment given | Other | No treatment given. Participants are to complete a questionnaire in the study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Qualitative assessments of perceived impact on daily life | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Perceived disease control | Day 1 | |
| Carrier status and reactions to haemophilia diagnosis | Day 1 | |
| Genetic counselling and testing |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult males with haemophilia and parents/carers of children with haemophilia.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452), GZZF | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Säo Paulo | 05001-400 | Brazil |
Not provided
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Day 1 |
| Impact of haemophilia in siblings | Day 1 |
| Satisfaction with support from partners, family, friends, others | Day 1 |
| Sexual intimacy with partners in long-term relationships | Day 1 |
| Treatment method, compliance and location | Day 1 |
| Modified WHO-5 (World Health Organization-Five Well Being Index) | Day 1 |
| Knowledge and information about haemophilia | Day 1 |
| Improvements in haemophilia care | Day 1 |
| ID | Term |
|---|---|
| D006467 | Hemophilia A |
| D002836 | Hemophilia B |
| ID | Term |
|---|---|
| D025861 | Blood Coagulation Disorders, Inherited |
| D001778 | Blood Coagulation Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D020147 | Coagulation Protein Disorders |
| D006474 | Hemorrhagic Disorders |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D040181 | Genetic Diseases, X-Linked |
Not provided
Not provided